MUTATION IN VIRUS AND GENETIC ALTERATION IN VIRUSES - A REVIEW
DOI:
https://doi.org/10.61841/3qbbd370Keywords:
Virus, Mutation rates, Radiation induced DNA damage, Cross species adaptation in viruses, Food preservatives, RecombinationAbstract
The remarkable capacity of some viruses to adjust and adapt to a new host and environment is highly dependent on the capacity to generate de Novo diversity in a short period. Rates of spontaneous mutation shift abundantly among viruses. RNA viruses change quicker than DNA viruses, single-stranded virus transforms quicker than double standard infection and genome size seems to connect adversely with transformation rate. Viral change rates are equalized at various stages, like polymerase fidelity, Sequence content, template secondary structure, cellular microenvironment, application mechanism, proofreading and post replication repair. The mutation rate of an organism is defined as the probability where a change in genetic information is passed to the next generation. In viruses, a generation is often defined as a cell infection cycle, which includes an attachment to the cell surface, entry, gene expression, replication, encapsidation, and release of infectious particles. Also, enormous quantities of changes can be presented by some virus-encoded diversity generating elements, as well as by host-encoded cystine/ adenosine deaminase. Our recent knowledge on viral change rates explains that viral hereditary variety is determined by multiple viruses and host interaction and the viral mutation rates can evolve in response to specific selective pressures.
Downloads
References
[1] Sanjuán R. Viral Mutation Rates. Virus Evolution: Current Research and Future Directions 2016:1–28. https://doi.org/10.21775/9781910190234.01.
[2] Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nature Reviews Genetics 2008;9:267–76. https://doi.org/10.1038/nrg2323.
[3] Perelson AS. Theoretical Immunology, Part Two. CRC Press; 2018.
[4] Schotsaert M, García-Sastre A. Influenza Vaccines: A Moving Interdisciplinary Field. Viruses 2014;6:3809–26. https://doi.org/10.3390/v6103809.
[5] Cao Y, Bao Y, Xia W, Wu H, Wei F, Zhang Y, et al. Resistance-associated mutations to HCV protease inhibitors naturally pre-existed in HIV/HCV coinfected, treatment-naïve patients. Clinics and Research in Hepatology and Gastroenterology 2016;40:597–604. https://doi.org/10.1016/j.clinre.2016.02.004.
[6] Anderson JP, Daifuku R, Loeb LA. Viral Error Catastrophe by Mutagenic Nucleosides. Annual Review of Microbiology 2004;58:183–205. https://doi.org/10.1146/annurev.micro.58.030603.123649.
[7] Bull JJ, Sanjuán R, Wilke CO. Theory of Lethal Mutagenesis for Viruses. Journal of Virology 2007;81:2930–9. https://doi.org/10.1128/jvi.01624-06.
[8] Domingo E, Martín V, Perales C, Grande-Pérez A, García-Arriaza J, Arias A. Viruses as Quasispecies: Biological Implications. Current Topics in Microbiology and Immunology 2006:51–82. https://doi.org/10.1007/3-540-26397-7_3.
[9] Crotty S, Cameron CE, Andino R. RNA virus error catastrophe: Direct molecular test by using ribavirin. Proceedings of the National Academy of Sciences 2001;98:6895–900. https://doi.org/10.1073/pnas.111085598.
[10] Holland JJ, Domingo E, de la Torre JC, Steinhauer DA. Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis.Journal of Virology 1990;64:3960–2. https://doi.org/10.1128/jvi.64.8.3960-3962.1990.
[11] Graci JD, Harki DA, Korneeva VS, Edathil JP, Too K, Franco D, et al. Lethal mutagenesis of poliovirus
mediated by a mutagenic pyrimidine analogue. J Virol 2007;81:11256–66.
[12] Ashwin KS, Muralidharan NP. Vancomycin-resistant enterococcus (VRE) vs Methicillin-resistant
Staphylococcus Aureus (MRSA). Indian J Med Microbiol 2015;33 Suppl:166–7.
[13] Shahana RY, Muralidharan NP. Efficacy of mouth rinse in maintaining oral health of patients attending
orthodontic clinics. Research Journal of Pharmacy and Technology 2016;9:1991. https://doi.org/10.5958/0974-
360x.2016.00406.6. (accessed June 16, 2020).
[14] Selvakumar R, Np M. COMPARISON IN BENEFITS OF HERBAL MOUTHWASHES WITH
CHLORHEXIDINE MOUTHWASH: A REVIEW. Asian Journal of Pharmaceutical and Clinical Research
2017;10:3. https://doi.org/10.22159/ajpcr.2017.v10i2.13304. (accessed June 16, 2020).
[15] Belshaw R, Sanjuán R, Pybus OG. Viral mutation and substitution: units and levels. Current Opinion in
Virology 2011;1:430–5. https://doi.org/10.1016/j.coviro.2011.08.004.
[16] Smiline ASG, Vijayashree JP, Paramasivam A. Molecular characterization of plasmid-encoded blaTEM,
blaSHV and blaCTX-M among extended-spectrum against enterococcuss] producing Acinetobacter baumannii.
British Journal of Biomedical Science 2018;75:200–2. https://doi.org/10.1080/09674845.2018.1492207.
(accessed June 16, 2020).
[17] Girija SAS, Jayaseelan VP, Arumugam P. Prevalence of VIM- and GIM-producing Acinetobacter baumannii
from patients with severe urinary tract infection. Acta Microbiologica et Immunologica Hungarica
2018;65:539–50. https://doi.org/10.1556/030.65.2018.038. (accessed June 16, 2020).
[18] Website n.d. Priyadharsini JV, Vijayashree Priyadharsini J, Smiline Girija AS, Paramasivam A. In silico
analysis of virulence genes in an emerging dental pathogen A. baumannii and related species. Archives of Oral
Biology 2018;94:93–8. https://doi.org/10.1016/j.archoralbio.2018.07.001. (accessed June 16, 2020).
[19] Garcin D, Itoh M, Kolakofsky D. A Point Mutation in the Sendai Virus Accessory C Proteins Attenuates
Virulence for Mice, but Not Virus Growth in Cell Culture. Virology 1997;238:424–31.
https://doi.org/10.1006/viro.1997.8836.
[20] Geetha RV, Thangavelu L, Others. Evaluation oEvaluation of anti-inflammatory action of Laurus nobilis-an in
vitro studyf anti-inflammatory action of Laurus nobilis-an in vitro study. International Journal of Research in
Pharmaceutical Sciences 2019;10:1209–13.
[21] Peace-Brewer AL, Tussey LG, Matsui M, Li G, Quinn DG, Frelinger JA. A Point Mutation in HLA-A*0201
Results in Failure to Bind the TAP Complex and to Present Virus-Derived Peptides to CTL. Immunity
1996;4:505–14. https://doi.org/10.1016/s1074-7613(00)80416-1.
[22] Gilbert C, Peccoud J, Chateigner A, Moumen B, Cordaux R, Herniou EA. Continuous Influx of Genetic
Material from Host to Virus Populations. PLOS Genetics 2016;12:e1005838.
https://doi.org/10.1371/journal.pgen.1005838.
[23] Website n.d. Holzerlandt, R., C. Orengo, P. Kellam, and M. M. Alba. 2002. “Identification of New
Herpesvirus Gene Homologs in the Human Genome.” Genome Research.
http://genome.cshlp.org/content/12/11/1739.short. (accessed June 8, 2020).
[24] Hughes AL, Friedman R. Poxvirus genome evolution by gene gain and loss. Molecular Phylogenetics and
Evolution 2005;35:186–95. https://doi.org/10.1016/j.ympev.2004.12.008.
[25] Adelman JP, Bond CT, Douglass J, Herbert E. Two mammalian genes transcribed from opposite strands of the
same DNA locus. Science 1987;235:1514–7.
[26] Barcellos-Hoff MH, Brooks AL. Extracellular signaling through the microenvironment: a hypothesis relating
carcinogenesis, bystander effects, and genomic instability. Radiat Res 2001;156:618–27.
[27] Chang WP, Little JB. Delayed reproductive death in X-irradiated Chinese hamster ovary cells. Int J Radiat
Biol 1991;60:483–96.
[28] Cremer M, von Hase J, Volm T, Brero A, Kreth G, Walter J, et al. Non-random radial higher-order chromatin
arrangements in nuclei of diploid human cells. Chromosome Res 2001;9:541–67.
[29] Hill MA. Radiation damage to DNA: the importance of track structure. Radiat Meas 1999;31:15–23.
[30] Khanna KK, Lavin MF, Jackson SP, Mulhern TD. ATM, a central controller of cellular responses to DNA
damage. Cell Death & Differentiation 2001;8:1052–65. https://doi.org/10.1038/sj.cdd.4400874.
[31] Liang L, Shao C, Deng L, Mendonca MS, Stambrook PJ, Tischfield JA. Radiation-induced genetic instability in vivo depends on p53 status. Mutat Res 2002;502:69–80.
[32] Clutton SM, Townsend KM, Walker C, Ansell JD, Wright EG. Radiation-induced genomic instability and
persisting oxidative stress in primary bone marrow cultures. Carcinogenesis 1996;17:1633–9.
[33] Podolin PL, Bolognese BJ, Foley JJ, Schmidt DB, Buckley PT, Widdowson KL, et al. A Potent and Selective
Nonpeptide Antagonist of CXCR2 Inhibits Acute and Chronic Models of Arthritis in the Rabbit. The Journal
of Immunology 2002;169:6435–44. https://doi.org/10.4049/jimmunol.169.11.6435.
[34] Yılmaz S, Ünal F, Yüzbaşıoğlu D. The in vitro genotoxicity of benzoic acid in human peripheral blood
lymphocytes. Cytotechnology 2009;60:55.
[35] Pandir D. DNA damage in human germ cell exposed to the some food additives in vitro. Cytotechnology
2016;68:725–33. https://doi.org/10.1007/s10616-014-9824-y.
[36] Tanaka R. INHIBITORY EFFECTS OF XANTHONE ON PARAQUAT- AND NaNO2-INDUCED
GENOTOXICITY IN CULTURED CELLS. The Journal of Toxicological Sciences 2007;32:571–4.
https://doi.org/10.2131/jts.32.571.
[37] Yılmaz S, Ünal F, Yüzbaşıoğlu D, Aksoy H. Clastogenic effects of food additive citric acid in human
peripheral lymphocytes. Cytotechnology 2008;56:137–44. https://doi.org/10.1007/s10616-008-9137-0.
[38] Biswas SJ, Khuda-Bukhsh AR. Cytotoxic and genotoxic effects of the azo-dye p-dimethylaminoazobenzene in
mice: A time-course study. Mutation Research/Genetic Toxicology and Environmental Mutagenesis
2005;587:1–8. https://doi.org/10.1016/j.mrgentox.2005.06.011.
[39] Zengin N, Yüzbaşıoğlu D, Ünal F, Yılmaz S, Aksoy H. The evaluation of the genotoxicity of two food
preservatives: Sodium benzoate and potassium benzoate. Food and Chemical Toxicology 2011;49:763–9.
https://doi.org/10.1016/j.fct.2010.11.040.
[40] Fadel HJ, Poeschla EM. Retroviral restriction and dependency factors in primates and carnivores. Veterinary
Immunology and Immunopathology 2011;143:179–89. https://doi.org/10.1016/j.vetimm.2011.06.002.
[41] Planelles V. SAMHD1 Joins the Red Queen’s Court. Cell Host & Microbe 2012;11:103–5.
https://doi.org/10.1016/j.chom.2012.02.001.
[42] Malim MH, Bieniasz PD. HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect
Med 2012;2:a006940.
[43] Meyerson NR, Sawyer SL. Two-stepping through time: mammals and viruses. Trends in Microbiology
2011;19:286–94. https://doi.org/10.1016/j.tim.2011.03.006.
[44] Sayah DM, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl
monkey resistance to HIV-1. Nature 2004;430:569–73. https://doi.org/10.1038/nature02777.
[45] Stremlau M, Perron M, Welikala S, Sodroski J. Species-Specific Variation in the B30.2(SPRY) Domain of
TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction. Journal of Virology
2005;79:3139–45. https://doi.org/10.1128/jvi.79.5.3139-3145.2005.
[46] Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to
interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2009;339:b3675–b3675.
https://doi.org/10.1136/bmj.b3675.
[47] Bootsma MCJ. The Effect of Public Health Measures on the 1918 Influenza Pandemic in U.S. Cities. 2007.
[48] Hatchett RJ, Mecher CE, Lipsitch M. Public health interventions and epidemic intensity during the 1918
influenza pandemic. Proc Natl Acad Sci U S A 2007;104:7582–7.
[49] Paramasivam A, Vijayashree Priyadharsini J, Raghunandhakumar S. N6-adenosine methylation (m6A): a
promising new molecular target in hypertension and cardiovascular diseases. Hypertens Res 2020;43:153–4.
[50] Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically Modeling SARS and Other Newly
Emerging Respiratory Illnesses. Epidemiology 2005;16:791–801.
https://doi.org/10.1097/01.ede.0000181633.80269.4c.
[51] Fouchier R, Kuiken T, Rimmelzwaan G, Osterhaus A. Global task force for influenza. Nature 2005;435:419–20. https://doi.org/10.1038/435419a.
[52] Martina BEE, Haagmans BL, Kuiken T, Fouchier RAM, Rimmelzwaan GF, van Amerongen G, et al. SARS virus infection of cats and ferrets. Nature 2003;425:915–915. https://doi.org/10.1038/425915a.
[53] Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005;437:209–14. https://doi.org/10.1038/nature04017.
[54] Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences 2004;101:6146–51. https://doi.org/10.1073/pnas.0307506101.
[55] Arenas M. Simulation of molecular data under diverse evolutionary scenarios. PLoS Comput Biol 2012;8:e1002495.
[56] Girija SA, Priyadharsini JV, Paramasivam A. Prevalence of carbapenem-hydrolyzing OXA-type β-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection. Acta Microbiologica et Immunologica Hungarica 2019:1–7. https://doi.org/10.1556/030.66.2019.030.
[57] Priyadharsini JV, Vijayashree Priyadharsini J, Smiline Girija AS, Paramasivam A. An insight into the emergence of Acinetobacter baumannii as an oro-dental pathogen and its drug resistance gene profile – An in silico approach. Heliyon 2018;4:e01051. https://doi.org/10.1016/j.heliyon.2018.e01051.
[58] Arenas M, Posada D. The Effect of Recombination on the Reconstruction of Ancestral Sequences. Genetics 2010;184:1133–9. https://doi.org/10.1534/genetics.109.113423.
[59] Awadalla P. The evolutionary genomics of pathogen recombination. Nature Reviews Genetics 2003;4:50–60. https://doi.org/10.1038/nrg964.
[60] Baltimore D. Expression of animal virus genomes. Bacteriological Reviews 1971;35:235–41. https://doi.org/10.1128/mmbr.35.3.235-241.1971.
[61] Chin MPS, Rhodes TD, Chen J, Fu W, Hu W-S. Identification of a major restriction in HIV-1 intersubtype recombination. Proceedings of the National Academy of Sciences 2005;102:9002–7. https://doi.org/10.1073/pnas.0502522102.
[62] Shahzan MS, Sohaib Shahzan M, Smiline Girija AS, Vijayashree Priyadharsini J. A computational study targeting the mutated L321F of ERG11 gene in C. albicans, associated with fluconazole resistance with bioactive compounds from Acacia nilotica. Journal de Mycologie Médicale 2019;29:303–9. https://doi.org/10.1016/j.mycmed.2019.100899.
[63] Murtaugh MP, Yuan S, Faaberg KS. Appearance of Novel PRRSV Isolates by Recombination in the Natural Environment. Advances in Experimental Medicine and Biology 2001:31–6. https://doi.org/10.1007/978-1-4615-1325-4_4.
[64] Website n.d. Neher, Richard A., and Thomas Leitner. 2010. “Recombination Rate and Selection Strength in HIV Intra-Patient Evolution.” PLoS Computational Biology 6 (1). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813257/. (accessed June 8, 2020).
[65] Girija ASS, Smiline Girija AS, Vijayashree Priyadharsini J, Paramasivam A. Plasmid-encoded resistance to trimethoprim/sulfamethoxazole mediated by dfrA1, dfrA5, sul1 and sul2 among Acinetobacter baumannii isolated from urine samples of patients with severe urinary tract infection. Journal of Global Antimicrobial Resistance 2019;17:145–6. https://doi.org/10.1016/j.jgar.2019.04.001.
[66] Website n.d. Vaishali M, Geetha RV. Antibacterial activity of Orange peel oil on Streptococcus mutans and Enterococcus-An In-vitro study. Research Journal of Pharmacy and Technology 2018;11:513. https://doi.org/10.5958/0974-360x.2018.00094.x. (accessed June 16, 2020).
[67] Töpfer A, Zagordi O, Prabhakaran S, Roth V, Halperin E, Beerenwinkel N. Probabilistic Inference of Viral Quasispecies Subject to Recombination. Journal of Computational Biology 2013;20:113–23. https://doi.org/10.1089/cmb.2012.0232.
[68] Website n.d. Pratha AA, Ashwatha Pratha A, Geetha RV. Awareness on Hepatitis-B vaccination among dental students-A Questionnaire Survey. Research Journal of Pharmacy and Technology 2017;10:1360. https://doi.org/10.5958/0974-360x.2017.00240.2. (accessed June 16, 2020).
[69] Marickar RF, Geetha RV, Neelakantan P. Efficacy of Contemporary and Novel Intracanal Medicaments againstEnterococcus Faecalis. Journal of Clinical Pediatric Dentistry 2014;39:47–50. https://doi.org/10.17796/jcpd.39.1.wmw9768314h56666.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
